Abstract
Hematopoietic stem cell therapy can control disease-related complications in neonatal disorders of newborns. The IL9-IL9R complex is one of the most multifunctional cytokine complexes that promote proliferation and differentiation of hematopoietic progenitors. However, the structure of this complex has not been determined yet. The present work demonstrates a de novo computational method for rational protein designing to recapitulate the structural relationship among IL9: IL9R complex. We employed a strategy to design mimics of IL-9 that binds to IL-9Rα by molecular modeling and protein–protein docking approach. For the simulation purpose, each complex was simulated under discrete setups (i) Apo: IL9; (ii) Apo: IL9R; (iii) IL9: IL9R complex. A 50 ns MD simulation was performed for Apo proteins, and a 35 ns simulation was run for the docked complex with a total number of 2027 of frames, both using 0.02 fs time step. The results revealed that the docked complex was stable, binding with a higher affinity at the site of the immunoglobin (Ig) domain, and elicit downstream cell signaling. Ig domain, fibronectin type III domain, and WSXWS motif were present in the modeled complex structure, which represents a highly promising target. The simulated complex reached an equilibrium state and indicate that THR52, SER53, CYS54, CYS56, GLU71, GLN75, ASN78, THR79, MET81, GLU110, PRO112, ASN114, GLN115 and ALA118 residues of IL9 structure were involved with THR53, PHE54, ALA70, PRO71, GLY74, GLU130, VAL132, SER133, LEU134, VAL135, ASP136, PRO137, GLU138, TYR241 and THR242 residues of IL9R structure. The data presented herein provide important insights into the molecular structure of IL9-IL9R complex and offers a promising target complex for drug design studies in the field of hematopoietic stem cell therapy.
Similar content being viewed by others
References
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Asamitsu K, Hirokawa T, Hibi Y, Okamoto T (2015) Molecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteins. PLoS ONE 10:e0119451
Ashworth A (1998) Effects of intrauterine growth retardation on mortality and morbidity in infants and young children. Eur J Clin Nutr 52:34–41
Bauer J, Bradl M, Hickey WF, Forss-Petter S, Breitschopf H, Linington C, Wekerle H, Lassmann H (1998) T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am J Pathol 153:715–724
Cavazzana-Calvo M, Fischer A (2007) Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Investig 117:1456–1465
Chen N, Wang X (2014) Role of IL-9 and STATs in hematological malignancies. Oncol Lett 7:602–610
Darnell SJ, LeGault L, Mitchell JC (2008) KFC Server: interactive forecasting of protein interaction hot spots. Nucleic Acids Res 36:W265–W269
De Smedt M, Verhasselt B, Kerre T, Vanhecke D, Naessens E, Leclercq G, Renauld JC, Van Snick J, Plum J (2000) Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol 164:1761–1767
DeLano WL (2002) PyMOL: An open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82–92
Demoulin JB, Renauld JC (1998) Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol 16:345–364
Donahue RE, Yang YC, Clark SC (1990) Human P40 T-cell growth factor (interleukin-9) supports erythroid colony formation. Blood 75:2271–2275
Dong YW, Liao ML, Meng XL, Somero GN (2018) Structural flexibility and protein adaptation to temperature: molecular dynamics analysis of malate dehydrogenases of marine molluscs. Proc Natl Acad Sci 115:1274–1279
Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M, Yokota S, Urata Y, Ueda Y, Yamagishi H, Sonoda Y (2002) Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol 30:1373–1380
Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449–461
Goswami R, Kaplan MH (2011) A brief history of IL-9. J Immunol 186:3283–3288
Hospital A, Goñi JR, Orozco M, Gelpí JL (2015) Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem 8:37–47
Jiang F, Zhou CY, Wu YD (2014) Residue-specific force field based on the protein coil library. RSFF1: modification of OPLS-AA/L. J Phys Chem B118:6983–6998
Kelsh R, You R, Horzempa C, Zheng M, McKeown-Longo PJ (2014) Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains. PLoS ONE 9:e102974
Madan A, Brozanski BS, Cole CH, Oden NL, Cohen G, Phelps DL (2005) A pulmonary score for assessing the severity of neonatal chronic lung disease. Pediatrics 115:e450–e457
Nizsalóczki E, Csomós I, Nagy P, Fazekas Z, Goldman CK, Waldmann TA, Damjanovich S, Vámosi G, Mátyus L, Bodnár A (2014) Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells. Chem Phys Chem 15:3969–3978
O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311–328
Podestà M, Bruschettini M, Cossu C, Sabatini F, Dagnino M, Romantsik O, Spaggiari GM, Ramenghi LA, Frassoni F (2015) Preterm cord blood contains a higher proportion of immature hematopoietic progenitors compared to term samples. PLoS ONE 10:e0138680. https://doi.org/10.1371/journal.pone.0138680
Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854
Robb L (2007) Cytokine receptors and hematopoietic differentiation. Oncogene 26:6715–6723
Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by γc family cytokines. Nat Rev Immunol 9:480
Schaafsma MR, Falkenburg JHF, Duinkerken N, Van Snick J, Landegent JE, Willemze R, Fibbe WE (1993) Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF. Ann Hematol 66:45–49
Siva Subramanian KN (2014) Extremely low birth weight infant. In: Pediatrics: cardiac disease and critical care medicine. Medscape https://emedicine.medscape.com/article/979717-overview. Accessed 6 Sept 2019
Soussi-Gounni A, Kontolemos M, Hamid Q (2001) Role of IL-9 in the pathophysiology of allergic diseases. J Allerg Clin Immunol 107:575–582
Spangler JB, Moraga I, Mendoza JL, Garcia KC (2015) Insights into cytokine–receptor interactions from cytokine engineering. Annu Rev Immunol 33:139–167
Takatsuka S, Yamada H, Haniuda K, Saruwatari H, Ichihashi M, Renauld JC, Kitamura D (2018) IL-9 receptor ignaling in memory B cells regulates humoral recall responses. Nat Immunol 19:1025–1034. https://doi.org/10.1038/s41590-018-0177-0
Thrasher AJ, Williams DA (2017) Evolving gene therapy in primary immunodeficiency. Mol Ther 25:1132–1141
Tovchigrechko A, Vakser IA (2006) GRAMM-X public web server for protein–protein docking. Nucleic Acids Res 34:W310–W314
Valero De Bernabé J, Soriano T, Albaladejo R, Juarranz M, Calle ME, Martínez D, Domínguez-Rojas V (2004) Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol 116:3–15
Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Prot Eng 8:127–134
Wang X, Lupardus P, Laporte SL, Garcia KC (2009) Structural biology of shared cytokine receptors. Annu Rev Immunol 27:29–60
Webb B, Sali A (2014) Protein structure modeling with MODELLER. Protein Struct Predict Springer 1137:1–15
Wisgrill L, Schüller S, Bammer M, Berger A, Pollak A, Radke TF, Kögler G, Spittler A, Helmer H, Husslein P, Gortner L (2014) Hematopoietic stem cells in neonates: any differences between very preterm and term neonates? PLoS ONE 9:e106717. https://doi.org/10.1371/journal.pone.0106717
Zhang JM, An J (2007) Cytokines, inflammation and pain. Int Anesthesiol Clin 45:27–37
Zhang CC, Lodish HF (2008) Cytokines regulating hematopoietic stem cell function. Curr Opin Hematol 15:307–311. https://doi.org/10.1097/MOH.0b013e3283007db5
Zheng M, Jones DM, Horzempa C, Prasad A, McKeown-Longo PJ (2011) The first type III domain of fibronectin is associated with the expression of cytokines within the lung tumor microenvironment. J Cancer 2:478–483
Acknowledgements
SS is thankful to the Department of Science and Technology, Govt. of India, for providing the INSPIRE fellowship. We gratefully acknowledge Bioinformatics Resources and Application Facility (BRAF) at C-DAC, Pune, for providing high-end supercomputing facilities for MD simulation.
Funding
This study was supported by Department of Science and Technology, Ministry of Science and Technology (Grant no. DST/INSPIRE Fellowship/2015/IF150234).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Singh, S., Chaturvedi, N. & Rai, G. De novo modeling and structural characterization of IL9-IL9 receptor complex: a potential drug target for hematopoietic stem cell therapy. Netw Model Anal Health Inform Bioinforma 9, 29 (2020). https://doi.org/10.1007/s13721-020-00236-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13721-020-00236-9